Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G K Thaker

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Current Psychiatry Reports|December 21, 2000
Defining the schizophrenia phenotypeG K Thaker
The American Journal of Psychiatry|September 1, 1992
Addition of fluoxetine to clozapineS L Cassady, G K Thaker
Nature Medicine|June 1, 2001
Advances in schizophreniaG K Thaker, W T Carpenter
Biological Psychiatry|November 1, 1985
Labile hypertension after antipsychotic drug withdrawal: a case reportG K Thaker, L Alphs, C A Tamminga
Schizophrenia Research|June 1, 1994
Psychosis-proneness and verbal memory in a college student populationD J LaPorte, B Kirkpatrick, G K Thaker
Archives of General Psychiatry|March 1, 1990
GABAmimetics: a new class of antidepressant agents?G K Thaker, M Moran, C A Tamminga
Modern Problems of Pharmacopsychiatry|January 1, 1983
GABA system: clinical research and treatment of tardive dyskinesiaG K Thaker, T A Hare, C A Tamminga
Biological Psychiatry|August 1, 1990
Sleep polygraphy in schizophrenia: methodological issuesG K Thaker, A M Wagman, C A Tamminga
Psychopharmacology Bulletin|January 1, 1993
Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patientsS L Cassady, G K Thaker, C A Tamminga
Psychopharmacology. Supplementum|January 1, 1985
GABA dysfunction in the pathophysiology of tardive dyskinesiaC A Tamminga, G K Thaker, T N Chase
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Psychiatry Reports|December 21, 2000
Defining the schizophrenia phenotypeG K Thaker
The American Journal of Psychiatry|September 1, 1992
Addition of fluoxetine to clozapineS L Cassady, G K Thaker
Nature Medicine|June 1, 2001
Advances in schizophreniaG K Thaker, W T Carpenter
Biological Psychiatry|November 1, 1985
Labile hypertension after antipsychotic drug withdrawal: a case reportG K Thaker, L Alphs, C A Tamminga
Schizophrenia Research|June 1, 1994
Psychosis-proneness and verbal memory in a college student populationD J LaPorte, B Kirkpatrick, G K Thaker
Archives of General Psychiatry|March 1, 1990
GABAmimetics: a new class of antidepressant agents?G K Thaker, M Moran, C A Tamminga
Modern Problems of Pharmacopsychiatry|January 1, 1983
GABA system: clinical research and treatment of tardive dyskinesiaG K Thaker, T A Hare, C A Tamminga
Biological Psychiatry|August 1, 1990
Sleep polygraphy in schizophrenia: methodological issuesG K Thaker, A M Wagman, C A Tamminga
Psychopharmacology Bulletin|January 1, 1993
Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patientsS L Cassady, G K Thaker, C A Tamminga
Psychopharmacology. Supplementum|January 1, 1985
GABA dysfunction in the pathophysiology of tardive dyskinesiaC A Tamminga, G K Thaker, T N Chase
Pageof 5